Vicore Pharma’s rights issue registered – conversion of BTA to shares

2018-11-01 | Regulatory

Not to be released, publication or distribution, directly or indirectly, in or to the United States, Australia, Hong Kong, Singapore, Canada, Japan, New Zealand or South Africa.

Mölndal, November 1, 2018 – Vicore Pharma Holding AB (publ) (”Vicore Pharma” or the ”Company”) has completed a rights issue with the subscription period ending on October 3, 2018. The share issue was oversubscribed with 33 percent and provided the Company with SEK 82,4M before issue costs. The rights issue has now been registered with the Swedish Companies Registration Office (sw. Bolagsverket) and last day of trading in paid subscribed shares (BTA) is on November 6, 2018. BTA will then be converted to shares which are expected to be visible on the respective shareholders’ VP account/custody account on November 12, 2018. The Company’s share is traded on Nasdaq First North.

After conversion of 8,240,002 BTA, the Company will have 32,960,008 outstanding shares.

ISIN code for the share (ticker: VICO): SE0007577895

ISIN code for the BTA (ticker: VICO BTA): SE0011670223

For further information, please contact:

Dr. Carl-Johan Dalsgaard, CEO: +46 709 759 863, carl-johan.dalsgaard@vicorepharma.com

Release